Search

Author/Creator Gergely, Peter

1. Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study. (March 2020)

Authors:
Fisher, Benjamin A; Szanto, Antonia; Ng, Wan-Fai; Bombardieri, Michele; Posch, Maximilian G; Papas, Athena S; Farag, Arwa M; Daikeler, Thomas; Bannert, Bettina; Kyburz, Diego; Kivitz, Alan J; Carsons, Steven E; Isenberg, David A; Barone, Francesca; Bowman, Simon J; Espié, Pascal; Floch, David; Du...
Journal:
Lancet
Issue:
Volume 2:Number 3(2020)
Page Start:
e142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome. Issue 7 (7th April 2022)

Authors:
Seror, Raphaele; Baron, Gabriel; Camus, Marine; Cornec, Divi; Perrodeau, Elodie; Bowman, Simon J; Bombardieri, Michele; Bootsma, Hendrika; Gottenberg, Jacques-Eric; Fisher, Benjamin; Hueber, Wolfgang; van Roon, Joel A; Devauchelle-Pensec, Valérie; Gergely, Peter; Mariette, Xavier; Porcher, Raphael
Other Names:
author non-byline.; Arends Suzanne author non-byline.; Barone Francesca author non-byline.; Björk Albin author non-byline.; Bouillot Coralie author non-byline.; Alegria Guillermo Carvajal author non-byline.; Chen Wen-Hung author non-byline.; Clark Kenneth author non-byline.; Delli Konstantina au...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 81:Issue 7(2022)
Page Start:
979
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. First‐in‐human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti‐CD40 monoclonal antibody. Issue 2 (6th December 2019)

Authors:
Espié, Pascal; He, YanLing; Koo, Phillip; Sickert, Denise; Dupuy, Cyrielle; Chokoté, Edwige; Schuler, Roland; Mergentaler, Heidi; Ristov, Jacinda; Milojevic, Julie; Verles, Aurelie; Groenewegen, Andrea; Auger, Anita; Avrameas, Alexandre; Rotte, Michael; Colin, Laurence; Tomek, Charles S.; Hernand...
Journal:
American journal of transplantation
Issue:
Volume 20:Issue 2(2020)
Page Start:
463
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. FRI0174 SUBCUTANEOUS DOSING OF THE NOVEL ANTI-CD40 ANTIBODY ISCALIMAB ACHIEVES TARGET DRUG EXPOSURE AND CLINICAL EFFICACY IN PRIMARY SJÖGREN'S SYNDROME; RESULTS OF A PHASE IIA RANDOMISED OPEN LABEL TWO ARM PARALLEL GROUP TRIAL. (June 2019)

Authors:
Fisher, Benjamin; Szántó, Antónia; Ng, Wan Fai; Bombardieri, Michele; Posch, Maximilian; Papas, Athena; Farag, Arwa; Daikeler, Thomas; Bannert, Bettina; Kivitz, Alan; Carsons, Steven; Isenberg, David; Barone, Francesca; Bowman, Simon J.; Espie, Pascal; Wieczorek, Grazyna; Moulin, Pierre; Floch, D...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
760
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pharmacological inhibition of porcupine induces regression of experimental skin fibrosis by targeting Wnt signalling. Issue 4 (2nd February 2017)

Authors:
Chen, Chih-Wei; Beyer, Christian; Liu, Jun; Maier, Christiane; Li, Chun; Trinh-Minh, Thuong; Xu, Xiaohan; Cole, Stuart H; Hsieh, Mindy H; Ng, Nicholas; Althage, Alana; Meeusen, Shelly; Pan, Shifeng; Svensson, Eric C; Seidel, H Martin; Schett, Georg; Gergely, Peter; Harris, Jennifer L; Distler, Jö...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76:Issue 4(2017)
Page Start:
773
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗